Literature DB >> 21360132

The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification.

Sumin Chae1, Anbok Lee, Joo-Ho Lee.   

Abstract

BACKGROUND: The most important prognostic factor after curative surgery for gastric carcinoma is the presence of lymph node metastases. According to the 7th edition of the UICC TNM staging system for gastric cancer, N classification was categorized as N0 (no regional lymph node metastasis), N1 (1-2 regional lymph node metastases), N2 (3-6 regional lymph node metastases), and N3 (7 or more regional lymph node metastases). The purpose of this study was to evaluate the rationality of the new UICC/AJCC N classification in comparison with the 6th UICC classification.
METHODS: From August 2002 to July 2006, 295 patients with gastric cancer underwent curative resection with D2 lymph node dissection by a single surgeon. We analyzed retrospectively the significant prognostic factors and identified the suitability of the 7th UICC N staging system.
RESULTS: According to the 7th UICC N classification, the 5-year cumulative survival rates (5-YSR) of N0, N1, N2, N3a, and N3b were 89.7, 73.6, 54.9, 23.1, and 5.4%, respectively (P < 0.0001). Using univariate analysis, the N classification of the 7th and 6th UICC/AJCC TNM staging system, T classification of the 7th UICC TNM staging system, size and location of tumor, and histology were associated with the overall survival of gastric cancer after curative surgery. However, Cox regression multivariate analysis showed the 7th UICC N classification was an independent prognostic factor instead of the 6th UICC N classification (P < 0.0001).
CONCLUSION: The 7th UICC classification for lymph node metastasis is thought to be a more reliable prognostic factor for gastric cancer than the 6th classification.

Entities:  

Mesh:

Year:  2011        PMID: 21360132     DOI: 10.1007/s10120-011-0024-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  24 in total

1.  The superiority of ratio-based lymph node staging in gastric carcinoma.

Authors:  Kentaro Inoue; Yasushi Nakane; Hitoshi Iiyama; Mutsuya Sato; Tatsuya Kanbara; Koji Nakai; Syunichiro Okumura; Keigo Yamamichi; Koshiro Hioki
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

2.  Determining prognostic factors for gastric cancer using the regression tree method.

Authors:  Yoshitaka Yamamura; Toshifusa Nakajima; Keiichiro Ohta; Atsushi Nashimoto; Kuniyoshi Arai; Masahiro Hiratsuka; Mitsuru Sasako; Yasuhiro Kodera; Masashi Goto
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

3.  Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer.

Authors:  R Persiani; S Rausei; A Biondi; S Boccia; F Cananzi; D D'Ugo
Journal:  Eur J Surg Oncol       Date:  2007-07-10       Impact factor: 4.424

4.  TNM: principles, history, and relation to other prognostic factors.

Authors:  L H Sobin
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

5.  [Prognostic factors in gastric cancer. Our experience and review of the literature].

Authors:  A Z Manfè; P Segalina; A Maffei Faccioli
Journal:  Minerva Chir       Date:  2000-05       Impact factor: 1.000

6.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.

Authors:  Jin-Pok Kim; Joo-Ho Lee; Soo-Jin Kim; Hang-Jong Yu; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  1998-03       Impact factor: 7.370

7.  Significant prognostic factors in patients with early gastric cancer.

Authors:  T Yokota; Y Kunii; S Teshima; Y Yamada; T Saito; M Takahashi; S Kikuchi; H Yamauchi
Journal:  Int Surg       Date:  2000 Oct-Dec

8.  Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma.

Authors:  H Katai; K Yoshimura; K Maruyama; M Sasako; T Sano
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

9.  Prediction of survival in gastric carcinoma related to lymph node grading by the new American Joint Committee on Cancer/Union International Contre le Cancer System or the Japanese system.

Authors:  Orhan Celen; Emin Yildirim; Kaptan Gülben; Uğur Berberoğlu
Journal:  Eur J Surg Suppl       Date:  2003-07

10.  Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value.

Authors:  E Klein Kranenbarg; J Hermans; J H van Krieken; C J van de Velde
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

View more
  39 in total

1.  Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

Authors:  Leyla Kilic; Cetin Ordu; Meltem Ekenel; Ibrahim Yildiz; Serkan Keskin; Fatma Sen; Zeynep Gural; Oktar Asoglu; Ahmet Kizir; Faruk Aykan
Journal:  Med Oncol       Date:  2013-07-23       Impact factor: 3.064

Review 2.  N staging system: tumor-node-metastasis and future perspectives.

Authors:  Federica Galli; Laura Ruspi; Alessandro Marzorati; Matteo Lavazza; Giuseppe Di Rocco; Luigi Boni; Gianlorenzo Dionigi; Stefano Rausei
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-17

3.  CT findings in diagnosis of gastric bare area invasion: potential prognostic factors for proximal gastric carcinoma.

Authors:  Rui-Jia Sun; Lei Tang; Xiao-Ting Li; Zi-Yu Li; Ying-Shi Sun
Journal:  Jpn J Radiol       Date:  2019-04-03       Impact factor: 2.374

4.  Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.

Authors:  Sevgi Ozden; Zerrin Ozgen; Hazan Ozyurt; Cengiz Gemici; Gokhan Yaprak; Huseyin Tepetam; Alpaslan Mayadagli
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

5.  DO PROXIMAL AND DISTAL GASTRIC TUMOURS BEHAVE DIFFERENTLY?

Authors:  Laurence Bedin da Costa; Marcelo Garcia Toneto; Luis Fernando Moreira
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

6.  Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis.

Authors:  Jianchun Gu; Leizhen Zheng; Yajie Wang; Meiling Zhu; Qin Wang; Xiaoping Li
Journal:  Tumour Biol       Date:  2014-02-21

Review 7.  Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.

Authors:  Jizhun Zhang; Yangbing Zhou; Kewei Jiang; Zhanlong Shen; Yingjiang Ye; Shan Wang
Journal:  Tumour Biol       Date:  2014-04-03

8.  Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7(th) edition and JCGS 13(th) edition N-classification systems.

Authors:  Xiang Hu; Liang Cao; Yi Yu
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

9.  Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients.

Authors:  Li Chen; Yan Shi; Jing Yuan; Qian Wu; Yalin Han; Rui Qin; Baoqing Jia; Bo Wei; Lixin Wei; Guanghai Dai; Shunchang Jiao
Journal:  Med Oncol       Date:  2014-08-14       Impact factor: 3.064

10.  Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project.

Authors:  Takeshi Sano; Daniel G Coit; Hyung Ho Kim; Franco Roviello; Paulo Kassab; Christian Wittekind; Yuko Yamamoto; Yasuo Ohashi
Journal:  Gastric Cancer       Date:  2016-02-20       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.